| Ms Carol L Mandigo, LICSW | |
|
6 S State St, Concord, NH 03301-3761 | |
| (603) 228-3862 | |
| (603) 226-0073 |
| Full Name | Ms Carol L Mandigo |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 43 Years |
| Location | 6 S State St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164690228 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 372 (New Hampshire) | Primary |
| Entity Name | Cornerstone Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457370629 PECOS PAC ID: 5193727121 Enrollment ID: O20070205000388 |
News Archive
News outlets report on developments regarding health exchanges in Maryland, Delaware and Oregon.
The Epilepsy Foundation has issued a Call to Action to women of childbearing age who take anticonvulsant medications for conditions that include epilepsy, migraine headaches, and certain psychiatric disorders, urging them to talk to their healthcare providers about treatment options.
Eastern Missouri Alternative Sentencing Services (EMASS) has announced that Saint Louis County Justice Services awarded their alcohol monitoring contract for the county's DUI offenders to EMASS and their transdermal alcohol sensors, known as SCRAM (Secure Continuous Remote Alcohol Monitors).
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire Français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has converted the convertible preferred stock it previously purchased in November 2009 under the terms described in the financing agreements approved by GTC shareholders in July 2009 into a total of 5.3 million shares of common stock.
› Verified 2 days ago
| Entity Name | Carol L. Mandigo Licsw Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760964639 PECOS PAC ID: 5698026375 Enrollment ID: O20180919000891 |
News Archive
News outlets report on developments regarding health exchanges in Maryland, Delaware and Oregon.
The Epilepsy Foundation has issued a Call to Action to women of childbearing age who take anticonvulsant medications for conditions that include epilepsy, migraine headaches, and certain psychiatric disorders, urging them to talk to their healthcare providers about treatment options.
Eastern Missouri Alternative Sentencing Services (EMASS) has announced that Saint Louis County Justice Services awarded their alcohol monitoring contract for the county's DUI offenders to EMASS and their transdermal alcohol sensors, known as SCRAM (Secure Continuous Remote Alcohol Monitors).
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire Français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has converted the convertible preferred stock it previously purchased in November 2009 under the terms described in the financing agreements approved by GTC shareholders in July 2009 into a total of 5.3 million shares of common stock.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Carol L Mandigo, LICSW 6 S State St, Concord, NH 03301-3761 Ph: (603) 228-3862 | Ms Carol L Mandigo, LICSW 6 S State St, Concord, NH 03301-3761 Ph: (603) 228-3862 |
News Archive
News outlets report on developments regarding health exchanges in Maryland, Delaware and Oregon.
The Epilepsy Foundation has issued a Call to Action to women of childbearing age who take anticonvulsant medications for conditions that include epilepsy, migraine headaches, and certain psychiatric disorders, urging them to talk to their healthcare providers about treatment options.
Eastern Missouri Alternative Sentencing Services (EMASS) has announced that Saint Louis County Justice Services awarded their alcohol monitoring contract for the county's DUI offenders to EMASS and their transdermal alcohol sensors, known as SCRAM (Secure Continuous Remote Alcohol Monitors).
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
GTC Biotherapeutics, Inc. announced that LFB Biotechnologies, a wholly owned subsidiary of LFB S.A. (Laboratoire Français du Fractionnement et des Biotechnologies S.A., Les Ulis, France) and a strategic shareholder in GTC, has converted the convertible preferred stock it previously purchased in November 2009 under the terms described in the financing agreements approved by GTC shareholders in July 2009 into a total of 5.3 million shares of common stock.
› Verified 2 days ago
Kyle Boston, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 West St, Concord, NH 03301 Phone: 603-225-0123 | |
Shannen Dufour, MSW, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 40 Pleasant St, Concord, NH 03301 Phone: 603-226-7505 | |
Ms. Judith Pregot, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 Ferry St, Concord, NH 03301 Phone: 800-370-3651 Fax: 877-515-7147 | |
Ms. Anne D Mccausland, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 8 Centre St, Suite 2, Concord, NH 03301 Phone: 603-228-7300 Fax: 603-228-7301 | |
Katherine Lipp, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10 West St, Concord, NH 03301 Phone: 603-225-0123 | |
Laura Conley, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 105 Loudon Rd Bldg 3, Concord, NH 03301 Phone: 603-228-0547 | |
Ms. Nicole Daune Goyette, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 13 Green St, Concord, NH 03301 Phone: 603-224-7479 Fax: 603-224-7445 |